Evidence map›Paper›PMID 32754447›Full record

ArticleFrontiers in oncology2020

Psychological Distress in Outpatients With Lymphoma During the COVID-19 Pandemic.

Francesca Romito, Miriam Dellino, Giacomo Loseto, Giuseppina Opinto, Erica Silvestris, Claudia Cormio, Attilio Guarini, Carla Minoia

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 5 pooled it
9.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 5 syntheses or guidelines pooled it, 120 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Patient-reported experiences of cancer care related to the COVID-19 pandemic in Switzerland.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Francesca RomitoPsycho-Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Miriam DellinoGynecology Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Giacomo LosetoHematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Giuseppina OpintoUnit of Hematology and Cell Therapy, Laboratory of Hematological Diagnostics and Cell Characterization, Bari, Italy.
Erica SilvestrisGynecology Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Claudia CormioPsycho-Oncology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Attilio GuariniHematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Carla MinoiaHematology Unit, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
Istituto Tumori Bari · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITInstitute of Cell Biology and Neurobiology · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer patients are a population at high risk of contracting COVID-19 and, also of developing severe complications due to the infection, which is especially true when they are undergoing immunosuppressive treatment. Despite this, they had still to go to hospital to receive chemotherapy during lockdown. In this context, we have evaluated the psychological status of onco-hematological outpatients receiving infusion and not deferrable anti-neoplastic treatment for lymphoproliferative neoplasms, with the aim of both measuring the levels of post-traumatic symptoms, depression, and anxiety during the pandemic and also of investigating the perception of risk of potential nosocomial infection. The Impact of Event Scale-Revised (IES-R) and the Hospital Anxiety and Depression Scale (HADS) were administered to all patients. Moreover, patients were investigated about their worries regarding the impact of COVID-19 on their lives as onco-hematologic patients. Since the 2nd to the 29th April 2020 (during the first phase of the lockdown period in Italy), 77 outpatients were prospectively evaluated. They were diagnosed with non-Hodgkin's lymphoma, classical Hodgkin lymphoma, and Chronic lymphocytic leukemia/Small lymphocytic lymphoma. The mean age was 56.6 (range 22-85). We found that 36% of patients had anxiety (HADS-A), 31% depression (HADS-D), and 43% were above the cut-off for the HADS-General Scale; 36% fulfilled the diagnostic criteria for post-traumatic stress disorder (PTSD). Women and younger patients were found to be more vulnerable to anxiety and PTSD. The study firstly analyzes the psychological impact of the COVID-19 pandemic on the frail population of patients affected by lymphoproliferative neoplasms, to underly the importance of screening patients for emotional and distress conditions and then offering them psychological support.

Indexed as

cancerCOVID-19lymphomapost-traumatic stress symptomspsychological distress

Identifiers

PMID32754447
PMCPMC7365920
OpenAlexW3041085727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.